BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19634916)

  • 21. Is there a role for circulating tumor cells in the management of breast cancer?
    Hayes DF; Smerage J
    Clin Cancer Res; 2008 Jun; 14(12):3646-50. PubMed ID: 18559576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating tumor cells.
    Hayes DF; Smerage JB
    Prog Mol Biol Transl Sci; 2010; 95():95-112. PubMed ID: 21075330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumor cells and bone marrow micrometastasis.
    Alix-Panabières C; Riethdorf S; Pantel K
    Clin Cancer Res; 2008 Aug; 14(16):5013-21. PubMed ID: 18698019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating tumor cells in patients undergoing surgery for primary breast cancer: preliminary results of a pilot study.
    Biggers B; Knox S; Grant M; Kuhn J; Nemunatitis J; Fisher T; Lamont J
    Ann Surg Oncol; 2009 Apr; 16(4):969-71. PubMed ID: 19190965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Image cytometry analysis of circulating tumor cells.
    Lowes LE; Goodale D; Keeney M; Allan AL
    Methods Cell Biol; 2011; 102():261-90. PubMed ID: 21704842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The emerging role of circulating tumor cell detection in genitourinary cancer.
    Small AC; Gong Y; Oh WK; Hall SJ; van Rijn CJ; Galsky MD
    J Urol; 2012 Jul; 188(1):21-6. PubMed ID: 22578722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controversies in circulating tumor cell count during therapy.
    Raimondi C; Gradilone A; Gazzaniga P
    Expert Rev Mol Diagn; 2013 Jun; 13(5):499-507. PubMed ID: 23782256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of circulating tumor cells by fluorescence in situ hybridization.
    Swennenhuis JF; Tibbe AG; Levink R; Sipkema RC; Terstappen LW
    Cytometry A; 2009 Jun; 75(6):520-7. PubMed ID: 19291800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.
    Zheng S; Lin H; Liu JQ; Balic M; Datar R; Cote RJ; Tai YC
    J Chromatogr A; 2007 Aug; 1162(2):154-61. PubMed ID: 17561026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
    Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
    Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical significance of circulating tumor cells in the peripheral blood.
    Elshimali YI; Grody WW
    Diagn Mol Pathol; 2006 Dec; 15(4):187-94. PubMed ID: 17122646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating tumour cell detection on its way to routine diagnostic implementation?
    Sleijfer S; Gratama JW; Sieuwerts AM; Kraan J; Martens JW; Foekens JA
    Eur J Cancer; 2007 Dec; 43(18):2645-50. PubMed ID: 17977713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating tumour cells in cancer patients: challenges and perspectives.
    Pantel K; Alix-Panabières C
    Trends Mol Med; 2010 Sep; 16(9):398-406. PubMed ID: 20667783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumor cells: detection, molecular profiling and future prospects.
    Jacob K; Sollier C; Jabado N
    Expert Rev Proteomics; 2007 Dec; 4(6):741-56. PubMed ID: 18067413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating and disseminated tumor cells in the management of breast cancer.
    Ross JS; Slodkowska EA
    Am J Clin Pathol; 2009 Aug; 132(2):237-45. PubMed ID: 19605818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical utility of circulating tumor cells: a role for monitoring response to therapy and drug development.
    Urtishak S; Alpaugh RK; Weiner LM; Swaby RF
    Biomark Med; 2008 Apr; 2(2):137-45. PubMed ID: 20477435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statistical considerations for enumeration of circulating tumor cells.
    Tibbe AG; Miller MC; Terstappen LW
    Cytometry A; 2007 Mar; 71(3):154-62. PubMed ID: 17200956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.
    Paris PL; Kobayashi Y; Zhao Q; Zeng W; Sridharan S; Fan T; Adler HL; Yera ER; Zarrabi MH; Zucker S; Simko J; Chen WT; Rosenberg J
    Cancer Lett; 2009 May; 277(2):164-73. PubMed ID: 19162393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case study of the morphologic variation of circulating tumor cells.
    Marrinucci D; Bethel K; Bruce RH; Curry DN; Hsieh B; Humphrey M; Krivacic RT; Kroener J; Kroener L; Ladanyi A; Lazarus NH; Nieva J; Kuhn P
    Hum Pathol; 2007 Mar; 38(3):514-9. PubMed ID: 17188328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.